Statements of Operations for the three and six months ended June 30, 1999 and 1998.......................... 4
Statements of Operations for the Years Ended December 31, 1998, 1997 and 1996.................................... 13
Statements of Operations. FISCAL YEARS ENDED -------------------------- DECEMBER 28, DECEMBER 29, 1997 1996 ------------ ------------ Revenue............................................ $ 67,952,893 $ 68,778,045 Costs and Expenses: Cost of products sold............................ 27,167,707 27,004,488 Salaries and benefits............................ 23,445,527 24,937,541 General and administrative....................... 43,689,673 37,330,992 Provision for store closures..................... 12,327,193 -- ------------ ------------ Total costs and expenses....................... 106,630,100 89,273,021 ------------ ------------ Loss From Operations............................... (38,677,207) (20,494,976) Other Income (Expense): Interest expense................................. (6,024,352) (3,318,215) Interest income.................................. 52,941 46,873 Other income (expense)........................... (1,445,316) 617,564 ------------ ------------ Total other expense............................ (7,416,727) (2,653,778) ------------ ------------ Net Loss........................................... $(46,093,934) $(23,148,754) ============ ============ The accompanying notes to financial statements are an integral part of these statements. F-32 FINEST FOODSERVICE, L.L.C. STATEMENTS OF MEMBERS' DEFICIT FOR THE YEARS ENDED DECEMBER 28, 1997 AND DECEMBER 29, 1996
Statements of Operations. 5 Statements of Stockholders' Equity (Deficit).............. 6
Statements of Operations. 38 Statement of Stockholders' Equity........................... 39 Statements of Cash Flows.................................... 40 Notes to Financial Statements............................... 41 REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS The Board of Directors and Stockholders Sangamo BioSciences, Inc. We have audited the accompanying balance sheets of Sangamo BioSciences, Inc. as of December 31, 2000 and 1999, and the related statements of operations, stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2000. These financial statements are the responsibility of the company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Sangamo BioSciences, Inc. at December 31, 2000 and 1999, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2000, in conformity with accounting principles generally accepted in the United States. Ernst & Young LLP Palo Alto, California January 26, 2001 SANGAMO BIOSCIENCES, INC. BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS) DECEMBER 31, ------------------- ASSETS 2000 -------- 1999 -------- Current assets: Cash and cash equivalents................................. $ 10,151 $ 251 Marketable securities..................................... 53,359 7,252 Interest receivable....................................... 1,171 -- Accounts receivable....................................... 1,506 562 Prepaid expenses.......................................... Total current assets.................................... 325 -------- 66,512 171 ------ 8,236 Property and equipment, net................................. 1,9...
Statements of Operations for the Years Ended December 31, 1997 and December 31, 1996, and for the Period from Reactivation [December 31, 1994] through December 31, 1997...........................4 Statements of Cash Flows for the Years Ended December 31, 1997 and December 31, 1996, and for the Period from Reactivation [December 31, 1994] through December 31, 1997...........................5
Statements of Operations. 36 Statements of Changes in Net Assets...................... 37
Statements of Operations. (g) The adjustments eliminate the historical results of CMC Sisak as if the transactions occurred on September 1, 2009. In accordance with accounting principles generally accepted in the United States, the amounts eliminated do not include corporate overhead and intercompany interest, which for segment reporting purposes, had been allocated to CMC Sisak. The tax adjustment for the year ended August 31, 2011 relates to the tax impact on the previously mentioned allocations as CMC Sisak had a full valuation allowance on its deferred tax assets.
Statements of Operations. Represents the elimination of High Voltage's historical operating results for the periods presented. The anticipated nonrecurring gain on the sale is not reflected in the unaudited pro forma condensed consolidated statements of operations.
Statements of Operations. Statements of operations of Xxxxxxxx for the fiscal years ended October 31, 1997 and October 31, 1996 certified by Xxxxxxx Xxxxxx & Co. which statements, together with any notes to the respective statements of income present fairly the results of operations of Xxxxxxxx for the said periods. Unaudited statements of operations of Sisters for the fiscal years ended October 31, 1997 and October 31, 1996 which statements, together with any notes to the respective statements of income present fairly the results of operations of Sisters for the said periods.
